Disequilibrium: Difference between revisions
No edit summary |
No edit summary |
||
Line 81: | Line 81: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Oncologic''' | | '''Oncologic''' | ||
|bgcolor="Beige"| [[Acoustic neuroma]], [[cerebellar tumors]], [[chondroma]], [[Ewing's sarcoma]], [[Hodgkin' lymphoma]], [[lung carcinoma]], [[neuroblastoma]], [[neurofibromatosis type 1]], [[non-Hodgkin's lymphoma]], [[osteochondroma]], [[osteoma]], [[osteosarcoma]], [[paraneoplastic syndrome]], [[rhadomyosarcoma]], [[solitary plasmacytoma]], [[spinal cord tumor]], | |bgcolor="Beige"| [[Acoustic neuroma]], [[Medulloblastoma|cerebellar tumors]], [[chondroma]], [[Ewing's sarcoma]], [[Hodgkin's lymphoma]], [[lung carcinoma]], [[neuroblastoma]], [[neurofibromatosis type 1]], [[Non-Hodgkin lymphoma|non-Hodgkin's lymphoma]], [[osteochondroma]], [[osteoma]], [[osteosarcoma]], [[paraneoplastic syndrome]], [[rhadomyosarcoma]], [[solitary plasmacytoma]], [[spinal cord tumor]], | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 89: | Line 89: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Overdose/Toxicity''' | | '''Overdose/Toxicity''' | ||
|bgcolor="Beige"| [[Alcohol toxicity]] | |bgcolor="Beige"| [[Ethanol|Alcohol toxicity]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 97: | Line 97: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Pulmonary''' | | '''Pulmonary''' | ||
|bgcolor="Beige"| [[Asthma exacerbation]], [[chronic obstructive pulmonary disease exacerbation]], [[diffuse pulmonary fibrosis]], [[pleural effusion]], [[pneumonia]], [[pneumothorax]], [[pulmonary edema]], [[pulmonary embolism]] | |bgcolor="Beige"| [[Asthma|Asthma exacerbation]], [[Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease exacerbation]], [[Idiopathic pulmonary fibrosis|diffuse pulmonary fibrosis]], [[pleural effusion]], [[pneumonia]], [[pneumothorax]], [[pulmonary edema]], [[pulmonary embolism]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 144: | Line 144: | ||
*[[AIDS]] | *[[AIDS]] | ||
*[[Alcohol dependence]] | *[[Alcohol dependence]] | ||
*[[Alcohol toxicity]] | *[[Ethanol|Alcohol toxicity]] | ||
*[[Alcoholic polyneuropathy]] | *[[Alcoholic polyneuropathy]] | ||
*[[Alpha-mannosidase deficiency]] | *[[Alpha-mannosidase deficiency]] | ||
Line 173: | Line 173: | ||
*[[Aspartoacylase deficiency ]] | *[[Aspartoacylase deficiency ]] | ||
*[[Aspirin]] | *[[Aspirin]] | ||
*[[Asthma exacerbation]] | *[[Asthma|Asthma exacerbation]] | ||
*[[Apraxia|Ataxia-oculomotor apraxia]] | *[[Apraxia|Ataxia-oculomotor apraxia]] | ||
*[[Ataxia-telangiectasia]] | *[[Ataxia-telangiectasia]] | ||
Line 224: | Line 224: | ||
*[[Chondroma]] | *[[Chondroma]] | ||
*[[Chronic liver disease]] | *[[Chronic liver disease]] | ||
*[[Chronic obstructive pulmonary disease exacerbation]] | *[[Chronic obstructive pulmonary disease|Chronic obstructive pulmonary disease exacerbation]] | ||
*[[Cinnarizine ]] | *[[Cinnarizine ]] | ||
*[[Cisplatin]] | *[[Cisplatin]] | ||
Line 263: | Line 263: | ||
*[[Diabetic neuropathy|Diabetic radiculopathy]] | *[[Diabetic neuropathy|Diabetic radiculopathy]] | ||
*[[Didmoad syndrome]] | *[[Didmoad syndrome]] | ||
*[[Diffuse pulmonary fibrosis]] | *[[Idiopathic pulmonary fibrosis|Diffuse pulmonary fibrosis]] | ||
*[[Schilder's disease|Diffuse sclerosis of schilder]] | *[[Schilder's disease|Diffuse sclerosis of schilder]] | ||
*[[Diphenhydramine]] | *[[Diphenhydramine]] | ||
Line 325: | Line 325: | ||
*[[Herpes zoster]] | *[[Herpes zoster]] | ||
*[[HIV]] | *[[HIV]] | ||
*[[Hodgkin' lymphoma]] | *[[Hodgkin's lymphoma]] | ||
*[[Ornithine translocase deficiency|Homocitrullinuria syndrome ]] | *[[Ornithine translocase deficiency|Homocitrullinuria syndrome]] | ||
*[[Hoyeraal-hreidarsson syndrome]] | *[[Hoyeraal-hreidarsson syndrome]] | ||
*[[Huntington disease]] | *[[Huntington disease]] | ||
Line 422: | Line 422: | ||
*[[Niemann-pick disease]] | *[[Niemann-pick disease]] | ||
*[[Nitrofurantoin]] | *[[Nitrofurantoin]] | ||
*[[Non- | *[[Non-Hodgkin's lymphoma]] | ||
*[[Normal pressure hydrocephalus]] | *[[Normal pressure hydrocephalus]] | ||
{{col-break|width=33%}} | {{col-break|width=33%}} |
Revision as of 03:01, 31 July 2013
WikiDoc Resources for Disequilibrium |
Articles |
---|
Most recent articles on Disequilibrium Most cited articles on Disequilibrium |
Media |
Powerpoint slides on Disequilibrium |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Disequilibrium at Clinical Trials.gov Trial results on Disequilibrium Clinical Trials on Disequilibrium at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Disequilibrium NICE Guidance on Disequilibrium
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Disequilibrium Discussion groups on Disequilibrium Patient Handouts on Disequilibrium Directions to Hospitals Treating Disequilibrium Risk calculators and risk factors for Disequilibrium
|
Healthcare Provider Resources |
Causes & Risk Factors for Disequilibrium |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Vendhan Ramanujam M.B.B.S [2]
Synonyms and keywords: Loss of balance; imbalance; off balance; unsteadiness
Overview
Disequilibrium refers to an impaired sense or absence of balance or equilibrioception, which primarily occurs during standing or walking usually without any cephalic sensations like headache, nausea and vomiting. It is one among the causes of dizziness[1] and is often accompanied by spatial disorientation.
Causes
Life Threatening Causes
Common Causes
Causes by Organ System
Causes in Alphabetical Order
References
- ↑ "Chapter 14: Evaluation of the Dizzy Patient". Retrieved 2009-08-06.